Prognostic factors of overall survival for patients with FIGO stage IIIc or IVa ovarian cancer treated with neo-adjuvant chemotherapy followed by interval debulking surgery: A multicenter cohort analysis from the FRANCOGYN study group-Reference-Cited by-同舟云学术

Prognostic factors of overall survival for patients with FIGO stage IIIc or IVa ovarian cancer treated with neo-adjuvant chemotherapy followed by interval debulking surgery: A multicenter cohort analysis from the FRANCOGYN study group

Published:2020-09 Issue:9 Volume:46 Page:1689-1696
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Vincent L.,Jankowski C.,Ouldamer L.,Ballester M.,Bendifallah S.,Bolze P.A.,Akladios C.,Costaz H.,Lavoué V.,Canlorbe G.,Collinet P.,Touboul C.,Huchon C.,Bricou A.,Dridi S.,Padéano M.M.,Bengrine L.,Arnould L.,Coutant C.

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference34 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;Ca - Cancer J Clin,2018

2. Carcinoma of the ovary. FIGO 26th annual report on the results of treatment in gynecological cancer;Heintz;Int J Gynaecol Obstet nov,2006

3. Staging classification for cancer of the ovary, fallopian tube, and peritoneum;Prat;Int. J. Gynaecol. Obstet. janv,2014

4. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer;Vergote;N Engl J Med,2010

5. Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: surgical and oncological outcomes. Single institution experience;Peiretti;Gynecol Oncol,2010

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of varying levels of residual disease following cytoreductive surgery on survival outcomes in patients with ovarian cancer: a meta-analysis;BMC Women's Health;2024-03-15

2. 3-4 Cycles vs 6 Cycles NACT in Advanced Stage Epithelial Ovarian Cancer: Survival is not Determined by the Number of NACT Cycles;Chemotherapy;2023-12-19

3. Correlation between progression-free survival and overall survival in patients with ovarian cancer after cytoreductive surgery: a systematic literature review;International Journal of Gynecologic Cancer;2023-08-29

4. Prognostic Factors and a Predictive Nomogram of Cancer-Specific Survival of Epithelial Ovarian Cancer Patients with Pelvic Exenteration Treatment;International Journal of Clinical Practice;2023-08-17

5. Enhanced recovery after surgery (ERAS) protocols in patients with advanced ovarian cancer undergoing ultra-radical cytoreductive surgery with intestinal resection and anastomosis: a retrospective study;European Journal of Gynaecological Oncology;2023